webinar register page

VACCINES SECURITY IN AFRICA – WHICH WAY NEXT?
Progressing the roadmap towards local vaccine development and manufacture in Africa Africa represents 14% of the world’s population but has only 0.1% of the world's vaccine production. With less than 10 countries being self-sufficient in vaccine procurement, most African countries rely on UNICEF and Gavi, the Vaccine Alliance for the supply of routine vaccinations, totaling over 1.5 billion doses annually. As has been witnessed with the COVID-19 pandemic, the over-reliance on external sources and procurement for vaccines renders the continent vulnerable to existing and future disease outbreaks.

The challenges faced on the continent in access to vaccines underscores the urgent need for locally produced and accessible vaccines as a public health security measure. Africa’s leaders are on a path to ramp up capacity in vaccine manufacturing and boost the continent’s regulatory bodies for medicines.

It is against this backdrop that IAVI and the African Vaccine Manufacturing Initiative (AVMI) are hosting a virtual forum to unpack the vaccine development and manufacturing landscape in Africa and advocate for a pathway towards local development and manufacture of vaccines. The forum will cast the spotlight on various initiatives to make local vaccine manufacture a reality including the collaboration between the Africa CDC and CEPI, the impending establishment of technology platforms by WHO, and ongoing end-to-end vaccine product development.
.

Aug 26, 2021 03:00 PM in Nairobi

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Ethel Makila.